These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24045230)

  • 81. Combined Nano-Vector Mediated-Transfer to Suppress HIV-1 Infection with Targeted Antibodies in-vitro.
    Yao X; Wang Q; Han C; Nie J; Chang Y; Xu L; Wu B; Yan J; Chen Z; Kong W; Shi Y; Shan Y
    Int J Nanomedicine; 2023; 18():4635-4645. PubMed ID: 37605734
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1.
    Solanki AK; Rathore YS; Badmalia MD; Dhoke RR; Nath SK; Nihalani D; Ashish
    J Biol Chem; 2014 Dec; 289(50):34780-800. PubMed ID: 25331945
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
    Kim SH; Song SH; Kim YJ; Park SY
    Mol Cells; 2001 Apr; 11(2):158-63. PubMed ID: 11355695
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Production of Secreted Antibody in Baculovirus Expression Vector System.
    Zhang Z; Zhang X; Liu L; Chen H
    Methods Mol Biol; 2024; 2829():175-183. PubMed ID: 38951333
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Broad and potent bispecific neutralizing antibody gene delivery using adeno-associated viral vectors for passive immunization against HIV-1.
    Li S; Qiao Y; Jiang S; Wang B; Kong W; Shan Y
    J Control Release; 2021 Oct; 338():633-643. PubMed ID: 34509584
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Abeta peptide.
    Tammer AH; Coia G; Cappai R; Fuller S; Masters CL; Hudson P; Underwood JR
    Clin Exp Immunol; 2002 Sep; 129(3):453-63. PubMed ID: 12197886
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12.
    Wu Y; West AP; Kim HJ; Thornton ME; Ward AB; Bjorkman PJ
    Cell Rep; 2013 Dec; 5(5):1443-55. PubMed ID: 24316082
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Delivery platforms for broadly neutralizing antibodies.
    Joshi LR; Gálvez NMS; Ghosh S; Weiner DB; Balazs AB
    Curr Opin HIV AIDS; 2023 Jul; 18(4):191-208. PubMed ID: 37265268
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Passive immunization against HIV/AIDS by antibody gene transfer.
    Yang L; Wang P
    Viruses; 2014 Jan; 6(2):428-47. PubMed ID: 24473340
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
    Casazza JP; Cale EM; Narpala S; Yamshchikov GV; Coates EE; Hendel CS; Novik L; Holman LA; Widge AT; Apte P; Gordon I; Gaudinski MR; Conan-Cibotti M; Lin BC; Nason MC; Trofymenko O; Telscher S; Plummer SH; Wycuff D; Adams WC; Pandey JP; McDermott A; Roederer M; Sukienik AN; O'Dell S; Gall JG; Flach B; Terry TL; Choe M; Shi W; Chen X; Kaltovich F; Saunders KO; Stein JA; Doria-Rose NA; Schwartz RM; Balazs AB; Baltimore D; Nabel GJ; Koup RA; Graham BS; Ledgerwood JE; Mascola JR;
    Nat Med; 2022 May; 28(5):1022-1030. PubMed ID: 35411076
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A comparative analysis of recombinant Fab and full-length antibody production in Chinese hamster ovary cells.
    Hussain H; Patel T; Ozanne AMS; Vito D; Ellis M; Hinchliffe M; Humphreys DP; Stephens PE; Sweeney B; White J; Dickson AJ; Smales CM
    Biotechnol Bioeng; 2021 Dec; 118(12):4815-4828. PubMed ID: 34585737
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer.
    Abdel-Motal UM; Harbison C; Han T; Pudney J; Anderson DJ; Zhu Q; Westmoreland S; Marasco WA
    Gene Ther; 2014 Sep; 21(9):802-10. PubMed ID: 24965083
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms.
    Moyo-Gwete T; Scheepers C; Makhado Z; Kgagudi P; Mzindle NB; Ziki R; Madzorera S; Manamela NP; Ayres F; Lambson BE; Richardson SI; Morris L; Moore PL
    Sci Rep; 2022 Oct; 12(1):16473. PubMed ID: 36182959
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.
    Whiteaker JR; Zhao L; Frisch C; Ylera F; Harth S; Knappik A; Paulovich AG
    J Proteome Res; 2014 Apr; 13(4):2187-96. PubMed ID: 24568200
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Development of a recombinant antibody to target peptides and proteins to sialoadhesin-expressing macrophages.
    Ooms K; Van Gorp H; Van Gaever T; Nauwynck HJ; Delputte PL
    BMC Biotechnol; 2013 Apr; 13():33. PubMed ID: 23575465
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations.
    Daftarian P; Chowdhury R; Ames P; Wei C; King AD; de Rivero Vaccari JP; Dillon L; Price J; Leung H; Ashlock B; Mesri E; Perez V; Züchner S; Reiser J; Lemmon V; Keane RW
    Hybridoma (Larchmt); 2011 Oct; 30(5):409-18. PubMed ID: 22008067
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Harnessing Avidity: Quantifying the Entropic and Energetic Effects of Linker Length and Rigidity for Multivalent Binding of Antibodies to HIV-1.
    Einav T; Yazdi S; Coey A; Bjorkman PJ; Phillips R
    Cell Syst; 2019 Nov; 9(5):466-474.e7. PubMed ID: 31668801
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies.
    Pagant S; Liberatore RA
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834297
    [TBL] [Abstract][Full Text] [Related]  

  • 99. AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
    Rosenberg JB; Hicks MJ; De BP; Pagovich O; Frenk E; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Tignor N; Mezey JG; Crystal RG
    Hum Gene Ther; 2012 May; 23(5):451-9. PubMed ID: 22486244
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Engineering strategies of Anti-HIV antibody therapeutics in clinical development.
    Pihlstrom N; Bournazos S
    Curr Opin HIV AIDS; 2023 Jul; 18(4):184-190. PubMed ID: 37144557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.